U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07361367) titled 'A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants' on Jan. 15.
Brief Summary: The objective of this study is to evaluate the PK of a tablet formulation of ABBV-722 under fasted conditions and the effect of food on its bioavailability after administration of single doses
Study Start Date: Jan. 12
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: ABBV-722
Oral Tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....